ClinicalTrials.Veeva

Menu

Gender-sensitive Enhancement of Common Weight Loss Strategies for Overweight and Obesity (I-GENDO)

O

Otto-Friedrich-University Bamberg

Status

Completed

Conditions

Weight Loss
Overweight and Obesity
Gender

Treatments

Behavioral: Smartphone-based interventional trial

Study type

Interventional

Funder types

Other

Identifiers

NCT04080193
DRKS00016623 (Registry Identifier)
71/02060305

Details and patient eligibility

About

The major aim of the proposed study is to develop a gender-sensitive individually tailored add-on intervention that focusses on improving individual gender-specific SIRs (subjective illness representations) in obese or overweight individuals. We will investigate whether this will improve compliance with and long-term success of common weight loss interventions. The effectiveness of this intervention in every-day-life with regard to weight-related behavioral changes and weight loss will be evaluated within a randomized controlled setting.To enhance the applicability of the intervention in every-day-life and its dissemination we plan to develop a smart-phone-based intervention.

Enrollment

213 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Obesity class I or II with subjectively experienced weight-related impairment and a current will to lose weight.
  2. Overweight (i.e. BMI between 25 and 29.9 kg/m²) with weight-related health problems and/or visceral adipose tissue and/or high psychosocial weight-related distress with a current will to lose weight.

Exclusion criteria

  1. Obesity Class III (i.e. BMI >39.9 kg/m²).
  2. Current (or within the last 12 months) involvement in a structured weight loss intervention.
  3. Insulin-dependent type 1 diabetes.
  4. Previous or intended bariatric surgery.
  5. Current psychotherapeutic treatment of weight-related health problems.
  6. Weight-enhancing drugs.
  7. Drugs which promote weight-loss (e.g. anti-obesity drugs).
  8. Weight-enhancing health problems which are not yet treated.
  9. Cancerous disease within the last five years.
  10. Current substance-use disorders, depression, psychosis, suicidal tendency or pregnancy.
  11. Severe cognitive impairments.
  12. Insufficient knowledge of the german language.
  13. Binge-Eating Disorder or Bulimia nervosa.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

213 participants in 2 patient groups

Intervention Group
Experimental group
Description:
The study will be a Smartphone-based interventional trial. To assess the effectiveness of the intervention weight- and eating-related behavior and cognitive and emotional responding as well as body-weight will be assessed using questionnaires and ecological momentary assessment (EMA) for one week at a pre- (T0), post- (T1) and two follow-up-assessments after six (T2) and 12 months (T3).
Treatment:
Behavioral: Smartphone-based interventional trial
Control Group
No Intervention group
Description:
Members of the control group will participate at each assessment. During the intervention phase they will receive treatment as usual.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems